Cargando…
The Hematopoietic Niche in Myeloproliferative Neoplasms
Specialized microanatomical areas of the bone marrow provide the signals that are mandatory for the maintenance and regulation of hematopoietic stem cells (HSCs) and progenitor cells. A complex microenvironment adjacent to the marrow vasculature (vascular niche) and close to the endosteum (endosteal...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677214/ https://www.ncbi.nlm.nih.gov/pubmed/26696752 http://dx.doi.org/10.1155/2015/347270 |
_version_ | 1782405293537230848 |
---|---|
author | Schmitt-Graeff, Annette H. Nitschke, Roland Zeiser, Robert |
author_facet | Schmitt-Graeff, Annette H. Nitschke, Roland Zeiser, Robert |
author_sort | Schmitt-Graeff, Annette H. |
collection | PubMed |
description | Specialized microanatomical areas of the bone marrow provide the signals that are mandatory for the maintenance and regulation of hematopoietic stem cells (HSCs) and progenitor cells. A complex microenvironment adjacent to the marrow vasculature (vascular niche) and close to the endosteum (endosteal niche) harbors multiple cell types including mesenchymal stromal cells and their derivatives such as CAR cells expressing high levels of chemokines C-X-C motif ligand 12 and early osteoblastic lineage cells, endothelial cells, and megakaryocytes. The characterization of the cellular and molecular networks operating in the HSC niche has opened new perspectives for the understanding of the bidirectional cross-talk between HSCs and stromal cell populations in normal and malignant conditions. A structural and functional remodeling of the niche may contribute to the development of myeloproliferative neoplasms (MPN). Malignant HSCs may alter the function and survival of MSCs that do not belong to the neoplastic clone. For example, a regression of nestin(+) MSCs by apoptosis has been attributed to neuroglial damage in MPN. Nonneoplastic MSCs in turn can promote aggressiveness and drug resistance of malignant cells. In the future, strategies to counteract the pathological interaction between the niche and neoplastic HSCs may offer additional treatment strategies for MPN patients. |
format | Online Article Text |
id | pubmed-4677214 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-46772142015-12-22 The Hematopoietic Niche in Myeloproliferative Neoplasms Schmitt-Graeff, Annette H. Nitschke, Roland Zeiser, Robert Mediators Inflamm Review Article Specialized microanatomical areas of the bone marrow provide the signals that are mandatory for the maintenance and regulation of hematopoietic stem cells (HSCs) and progenitor cells. A complex microenvironment adjacent to the marrow vasculature (vascular niche) and close to the endosteum (endosteal niche) harbors multiple cell types including mesenchymal stromal cells and their derivatives such as CAR cells expressing high levels of chemokines C-X-C motif ligand 12 and early osteoblastic lineage cells, endothelial cells, and megakaryocytes. The characterization of the cellular and molecular networks operating in the HSC niche has opened new perspectives for the understanding of the bidirectional cross-talk between HSCs and stromal cell populations in normal and malignant conditions. A structural and functional remodeling of the niche may contribute to the development of myeloproliferative neoplasms (MPN). Malignant HSCs may alter the function and survival of MSCs that do not belong to the neoplastic clone. For example, a regression of nestin(+) MSCs by apoptosis has been attributed to neuroglial damage in MPN. Nonneoplastic MSCs in turn can promote aggressiveness and drug resistance of malignant cells. In the future, strategies to counteract the pathological interaction between the niche and neoplastic HSCs may offer additional treatment strategies for MPN patients. Hindawi Publishing Corporation 2015 2015-11-30 /pmc/articles/PMC4677214/ /pubmed/26696752 http://dx.doi.org/10.1155/2015/347270 Text en Copyright © 2015 Annette H. Schmitt-Graeff et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Schmitt-Graeff, Annette H. Nitschke, Roland Zeiser, Robert The Hematopoietic Niche in Myeloproliferative Neoplasms |
title | The Hematopoietic Niche in Myeloproliferative Neoplasms |
title_full | The Hematopoietic Niche in Myeloproliferative Neoplasms |
title_fullStr | The Hematopoietic Niche in Myeloproliferative Neoplasms |
title_full_unstemmed | The Hematopoietic Niche in Myeloproliferative Neoplasms |
title_short | The Hematopoietic Niche in Myeloproliferative Neoplasms |
title_sort | hematopoietic niche in myeloproliferative neoplasms |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677214/ https://www.ncbi.nlm.nih.gov/pubmed/26696752 http://dx.doi.org/10.1155/2015/347270 |
work_keys_str_mv | AT schmittgraeffannetteh thehematopoieticnicheinmyeloproliferativeneoplasms AT nitschkeroland thehematopoieticnicheinmyeloproliferativeneoplasms AT zeiserrobert thehematopoieticnicheinmyeloproliferativeneoplasms AT schmittgraeffannetteh hematopoieticnicheinmyeloproliferativeneoplasms AT nitschkeroland hematopoieticnicheinmyeloproliferativeneoplasms AT zeiserrobert hematopoieticnicheinmyeloproliferativeneoplasms |